Efficacy of two brands of Mebendazole (500 mg) in the treatment of Ascaris lumbricoides and hookworm infection among school-aged children in South Gondar zone, Northwest Ethiopia: a randomized open label trial
This trial was retrospectively registered on https://pactr.samrc.ac.za/ and the unique identification number for registry was PACTR202503808932606 and the registration date was 27 March 2025.
Authors
- Gashaw Azanaw Amare (ORCID: https://orcid.org/0009-0001-4803-1514)
- Abebaw Setegn (ORCID: https://orcid.org/0009-0005-5950-5438)
- Tegegne Eshetu (ORCID: https://orcid.org/0000-0003-3861-6954)
- Birhanu Malede (ORCID: https://orcid.org/0009-0004-1337-5722)
- Hailegebriel Wondimu (ORCID: https://orcid.org/0000-0002-7166-7457)
- Ayenew Berhan (ORCID: https://orcid.org/0000-0002-2244-4476)
- Ayalew Jejaw Zeleke (ORCID: https://orcid.org/0000-0002-9640-4784)
- Tadesse Misganaw (ORCID: https://orcid.org/0000-0001-7994-3797)
- Yenesew Mihret Wondmagegn (ORCID: https://orcid.org/0009-0001-3797-6096)
Institutions
- Debre Tabor University (ET)
- Woldia University (ET)
- University of Gondar (ET)
- Debre Markos University (ET)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1186/s12879-025-11462-9
- Primary Topic
- Parasites and Host Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Gondar